We have previously shown that cultured RBL-2H3 cells, a mast cell line, generate physiologically significant concentrations of the cytokines, TNFalpha and IL-6 in response to antigen and other stimulants. Both production and release of these cytokines are dependent on cell stimulation and both appear to be separately regulated processes. Production of TNFalpha, for example, is dependent on mobilization of Ca2+, activation of protein kinase C (PKC) and a third synergising signal that is particularly strong in antigen-stimulated cells. Secretion of the newly formed TNFalpha via Golgi is dependent on mobilization of Ca2+ and activation of PKC and is readily blocked by inhibitors of PKC. We have now tentatively identified the Mitogen Activated Protein (MAP) kinase pathway as the third synergising signal for production of TNFalpha on the following basis. Of all stimulants tested, antigen is by far the most potent stimulant of this pathway (see report ZO1 HL 00937-14 LMI). The MAP kinase pathway (see last years report ZO1 HL 00937-13) and production of TNFalpha are both inhibited by nanomolar concentrations of the glucocorticoid, dexamethasone, or concentrations that have minimal effects on other stimulatory events in RBL-2H3 cells. Expression of dominant negative Raf, a MAP-kinase-regulatory protein in RBL-2H3 cells, results in markedly reduced activation of MAP kinase and production of TNFalpha. Expression of this protein, however, does not impede secretion of the small amounts of TNFalpha that are formed, consistent with previous indications that a third synergising signal is not required for release of TNF alpha. In contrast to the TNFalpha, the anti-inflammatory cytokine, TGFbeta, is constitutively produced and secreted via Golgi in RBL-2H3 cells and these processes were not inhibited by dexamethasone of inhibitors of PKC. A small increase in production and secretion of TGFbeta could be induced by antigen and this increase could be blocked by PKC inhibitors and dexamethasone. Therefore, although both types of cytokines were processed by Golgi, only TNFalpha and the inducible component of TGFbeta production were protein kinase C or steroid-regulated processes. These findings suggested that constitutive and inducible pathways exist for production and release of cytokines and that the inducible pathways can be selectively suppressed by pharmacologic agents.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Intramural Research (Z01)
Project #
1Z01HL000990-10
Application #
2576756
Study Section
Special Emphasis Panel (LMI)
Project Start
Project End
Budget Start
Budget End
Support Year
10
Fiscal Year
1996
Total Cost
Indirect Cost
Name
National Heart, Lung, and Blood Institute
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Jensen, Bettina M; Beaven, Michael A; Iwaki, Shoko et al. (2008) Concurrent inhibition of kit- and FcepsilonRI-mediated signaling: coordinated suppression of mast cell activation. J Pharmacol Exp Ther 324:128-38
Kuehn, Hye Sun; Beaven, Michael A; Ma, Hong-Tao et al. (2008) Synergistic activation of phospholipases Cgamma and Cbeta: a novel mechanism for PI3K-independent enhancement of FcepsilonRI-induced mast cell mediator release. Cell Signal 20:625-36
Lee, Jun Ho; Kim, Jie Wan; Ko, Na Young et al. (2008) Curcumin, a constituent of curry, suppresses IgE-mediated allergic response and mast cell activation at the level of Syk. J Allergy Clin Immunol 121:1225-31
Furumoto, Yasuko; Brooks, Steve; Olivera, Ana et al. (2006) Cutting Edge: Lentiviral short hairpin RNA silencing of PTEN in human mast cells reveals constitutive signals that promote cytokine secretion and cell survival. J Immunol 176:5167-71
Qiao, Huihong; Andrade, Marcus V; Lisboa, Felipe A et al. (2006) FcepsilonR1 and toll-like receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells. Blood 107:610-8
Hiragun, Takaaki; Peng, Ze; Beaven, Michael A (2006) Cutting edge: dexamethasone negatively regulates Syk in mast cells by up-regulating SRC-like adaptor protein. J Immunol 177:2047-50
Hiragun, Takaaki; Peng, Ze; Beaven, Michael A (2005) Dexamethasone up-regulates the inhibitory adaptor protein Dok-1 and suppresses downstream activation of the mitogen-activated protein kinase pathway in antigen-stimulated RBL-2H3 mast cells. Mol Pharmacol 67:598-603
Andrade, Marcus V M; Hiragun, Takaaki; Beaven, Michael A (2004) Dexamethasone suppresses antigen-induced activation of phosphatidylinositol 3-kinase and downstream responses in mast cells. J Immunol 172:7254-62
Hundley, Thomas R; Gilfillan, Alasdair M; Tkaczyk, Christine et al. (2004) Kit and FcepsilonRI mediate unique and convergent signals for release of inflammatory mediators from human mast cells. Blood 104:2410-7
Kirshenbaum, Arnold S; Akin, Cem; Wu, Yalin et al. (2003) Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI. Leuk Res 27:677-82

Showing the most recent 10 out of 13 publications